Novartis is teaming up with smartpatient to launch a new app feature on the MyTherapy app for patients with wet macular degeneration (AMD) that is focused on educating patients and caregivers about treatment and management.
Called "See What’s Next," the section was specifically designed to help provide patients and their families with resources about navigating life with the disease and giving...
The FDA has granted Class II prescription-only 510(K) clearance for an iPhone-enabled vision test. The software, called myVisionTrack, was developed by Vital Art and Science. The FDA clearance applies to the software when run on an iPhone 4S.
Vital Art and Science has developed the test for patients with serious degenerative eye conditions such as diabetic retinopathy (DR) and age-related macular...
When Fraser Edward joined Research In Motion (the company behind BlackBerry) four years ago, the device maker had only three partners for mobile healthcare applications, Edward said during a panel session at the American Telemedicine Association in Las Vegas. Today, Edward is RIM's business manager of market development for Health & Life Sciences, and the company has 30 healthcare...
